• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804400-18
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hypersensitivity/Allergic reaction (1907); Inflammation (1932); Pain (1994); Swelling/ Edema (4577)
Date of Event 04/14/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the procedure was to treat a lesion in the right coronary artery (rca).The 4.0x18mm xience skypoint stent was implanted on (b)(6) 2023.On (b)(6) 2023, the patient complained of itchy hands and feet, flushing, and hives.He took zyrtec and benadryl and the symptoms subsided for a day.The following day, (b)(6) 2023, he experienced hiccups that lasted all day long, and difficulty swallowing due to pressure and pain in his throat.Eating and drinking liquids was difficult due to the pain in his throat.He went to urgent care where a computed tomography (ct) scan was performed which showed irritation of the chest and inflammation around the heart.The physician could not explain anything and suggested he follow up with his primary care physician.He followed up with his primary care physician; however, an endoscopy procedure could not be performed due to the discomfort in his throat.He then started to feel immense pain in his joints and could not walk.He consulted with a rheumatologist and blood work was performed which showed inflammatory markers were elevated.He was prescribed prednisone for the joint pain.The joint pain was better by (b)(6) 2023.He then saw a gastroenterologist who did not find anything to be a cause of the inflammation or pain/swelling in the throat.He was then admitted into the hospital on (b)(6) 2023 due to the throat pain/swelling and diarrhea.He was administered medication and iv liquids however he started experiencing burning of the mouth and skin sensitivity.The only known allergies are to niacin, which he had similar reactions to.The patient is still in the hospital.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.The reported patient effects of pain, edema and hypersensitivity are listed in the xience skypoint, everolimus eluting coronary stent system (eecss), electronic instructions for use, as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the reported treatments appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16881363
Report Number2024168-2023-04807
Device Sequence Number5717862
Product Code NIQ
UDI-Device Identifier08717648233487
UDI-Public08717648233487
Combination Product (Y/N)Y
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/18/2026
Device Model Number1804400-18
Device Catalogue Number1804400-18
Device Lot Number3012441
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/24/2023
Initial Report FDA Received Date05/05/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/19/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age51 YR
Patient SexMale
Patient Weight91 KG
-
-